Oddo BHF Asset Management Sas Acquires Shares of 8,065 HCA Healthcare, Inc. (NYSE:HCA)

Oddo BHF Asset Management Sas purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,065 shares of the company's stock, valued at approximately $3,278,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Terra Nova Asset Management LLC boosted its position in shares of HCA Healthcare by 0.3% during the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company's stock worth $3,297,000 after buying an additional 26 shares during the period. Massmutual Trust Co. FSB ADV grew its stake in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company's stock worth $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC lifted its position in shares of HCA Healthcare by 1.8% in the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company's stock worth $683,000 after purchasing an additional 29 shares in the last quarter. Brookstone Capital Management increased its stake in HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company's stock valued at $1,652,000 after buying an additional 30 shares during the last quarter. Finally, UMB Bank n.a. boosted its stake in shares of HCA Healthcare by 2.4% during the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company's stock worth $529,000 after buying an additional 30 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent analyst reports. Barclays cut their price objective on HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating for the company in a report on Friday, November 8th. Wolfe Research raised shares of HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Cantor Fitzgerald reissued an "overweight" rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wells Fargo & Company lowered HCA Healthcare from an "equal weight" rating to an "underweight" rating and decreased their target price for the stock from $400.00 to $320.00 in a report on Monday, November 25th. Finally, Oppenheimer upped their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an "outperform" rating in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $387.13.

Insider Buying and Selling at HCA Healthcare

In other news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company's stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company's stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded up $2.59 during midday trading on Friday, hitting $313.93. 1,324,454 shares of the company traded hands, compared to its average volume of 1,204,023. The stock has a market cap of $79.52 billion, a price-to-earnings ratio of 14.01, a PEG ratio of 1.21 and a beta of 1.63. HCA Healthcare, Inc. has a 12 month low of $263.22 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm's fifty day moving average price is $356.94 and its 200-day moving average price is $358.27.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.84%. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.